Literature DB >> 26419803

Corrigendum: Combined CSL and p53 downregulation promotes cancer-associated fibroblast activation.

Maria-Giuseppina Procopio, Csaba Laszlo, Dania Al Labban, Dong Eun Kim, Pino Bordignon, Seung-Hee Jo, Sandro Goruppi, Elena Menietti, Paola Ostano, Ugo Ala, Paolo Provero, Wolfram Hoetzenecker, Victor Neel, Witold W Kilarski, Melody A Swartz, Cathrin Brisken, Karine Lefort, G Paolo Dotto.   

Abstract

Entities:  

Year:  2015        PMID： 26419803     DOI： 10.1038/ncb3242

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN： 1465-7392            Impact factor:   28.824


× No keyword cloud information.
  1 in total

1.  Combined CSL and p53 downregulation promotes cancer-associated fibroblast activation.

Authors:  Maria-Giuseppina Procopio; Csaba Laszlo; Dania Al Labban; Dong Eun Kim; Pino Bordignon; Seung-Hee Jo; Sandro Goruppi; Elena Menietti; Paola Ostano; Ugo Ala; Paolo Provero; Wolfram Hoetzenecker; Victor Neel; Witold W Kilarski; Melody A Swartz; Cathrin Brisken; Karine Lefort; G Paolo Dotto
Journal:  Nat Cell Biol       Date:  2015-08-24       Impact factor: 28.824
  1 in total
  2 in total

1.  PRL-3 promotes breast cancer progression by downregulating p14ARF-mediated p53 expression.

Authors:  Hua Xie; Hao Wang
Journal:  Oncol Lett       Date:  2017-12-19       Impact factor: 2.967

2.  Tracking Photodynamic- and Chemotherapy-Induced Redox-State Perturbations in 3D Culture Models of Pancreatic Cancer: A Tool for Identifying Therapy-Induced Metabolic Changes.

Authors:  Mans Broekgaarden; Anne-Laure Bulin; Jane Frederick; Zhiming Mai; Tayyaba Hasan
Journal:  J Clin Med       Date:  2019-09-06       Impact factor: 4.241
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.